Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q1
Sell
-68
Closed -$19.6K 306
2023
Q4
$19.6K Buy
+68
New +$18.5K ﹤0.01% 204
2023
Q3
Sell
-165
Closed -$36.6K 288
2023
Q2
$36.6K Sell
165
-17
-9% -$3.94K ﹤0.01% 193
2023
Q1
$44K Sell
182
-551
-75% -$135K ﹤0.01% 193
2022
Q4
$193K Sell
733
-295
-29% -$79.1K 0.01% 100
2022
Q3
$235K Sell
1,028
-32
-3% -$7.76K 0.01% 121
2022
Q2
$258K Buy
1,060
+691
+187% +$169K ﹤0.01% 122
2022
Q1
$89K Buy
+369
New +$84.8K ﹤0.01% 282
2020
Q4
Sell
-103
Closed -$26K 395
2020
Q3
$26K Sell
103
-15
-13% -$3.72K ﹤0.01% 299
2020
Q2
$28K Buy
118
+12
+11% +$2.74K ﹤0.01% 232
2020
Q1
$22K Sell
106
-66
-38% -$14.4K ﹤0.01% 229
2019
Q4
$42K Buy
172
+126
+274% +$27.8K ﹤0.01% 196
2019
Q3
$9K Buy
+46
New +$8.83K ﹤0.01% 287
2019
Q1
Sell
-41
Closed -$8K 298
2018
Q4
$8K Buy
+41
New +$8K ﹤0.01% 185
2018
Q3
Sell
-173
Closed -$9K 251
2018
Q2
$9K Buy
+173
New +$30.6K ﹤0.01% 152

Other funds holding AMGN

Altshuler Shaham's AMGN Position: Q1 2024 in Review

Altshuler Shaham sold out of Amgen (AMGN) in Q1 2024, closing a stake of 68 shares — an estimated $19.6K sold.

Altshuler Shaham first reported a position in AMGN in Q2 2018 and held it in 14 quarters. The position peaked at $258K in Q2 2022. 2,715 funds tracked by Wall St. Rank hold AMGN as of Q1 2024.

  • Altshuler Shaham reported no remaining Amgen position as of Q1 2024 after selling out during the quarter.
  • Altshuler Shaham sold 68 Amgen shares in Q1 2024, an estimated $19.6K.
  • Altshuler Shaham first reported a position in Amgen in Q2 2018 and held it in 14 quarters.
  • Altshuler Shaham's Amgen position peaked at $258K in Q2 2022.
  • 2,715 funds tracked by Wall St. Rank held Amgen as of Q1 2024.

Based on Altshuler Shaham's 13F filing for Q1 2024, filed 15 May 2024.